VanEck Vectors Biotech ETF (BBH) Declines 0.75% for May 17

May 17 is a negative day so far for VanEck Vectors Biotech ETF (NYSEARCA:BBH) as the ETF is active during the day after losing 0.75% to hit $120.04 per share. The exchange traded fund has 387.97 million net assets and 1.95% volatility this month.

Over the course of the day 8,088 shares traded hands, as compared to an average volume of 15,770 over the last 30 days for VanEck Vectors Biotech ETF (NYSEARCA:BBH).

The ETF is -12.69% of its 52-Week High and 15.71% of its low, and is currently having ATR of 2.49. This year’s performance is 7.90% while this quarter’s performance is -5.94%.

The ETF’s YTD performance is 11.34%, the 1 year is 7.25% and the 3 year is 5.55%.

The ETF’s average P/E ratio is 15.12, the price to book is 3.08, the price to sales is 4.81 and the price to cashflow is 12.78. It was started on 11/23/1999. The fund’s top holdings are: Amgen Inc for 8.44% of assets, Gilead Sciences Inc for 6.71%, Celgene Corp for 5.94%, Allergan PLC for 5.49%, Illumina Inc for 5.37%, Exact Sciences Corp for 5.33%, IQVIA Holdings Inc for 5.13%, Alexion Pharmaceuticals Inc for 4.80%, Vertex Pharmaceuticals Inc for 4.79%, Biomarin Pharmaceutical Inc for 4.34%. The ETF sector weights are: Basic Materials 0.00%, CONSUMER_CYCLICAL 0.00%, Financial Services 0.00%, Realestate 0.00%, Consumer Defensive 0.00%, Healthcare 100.00%, Utilities 0.00%, Communication Services 0.00%, Energy 0.00%, Industrials 0.00%, Technology 0.00%. The ETF currently as 0.45% yield.

More notable recent VanEck Vectors Biotech ETF (NASDAQ:BBH) news were published by: which released: “Will Biotech ETFs Continue to Rally in Q1 Earnings? – Nasdaq” on April 24, 2019, also with their article: “Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 16, 2019 – Nasdaq” published on May 15, 2019, published: “Sri Lanka may need more IMF help as blasts threaten tourism – Nasdaq” on April 23, 2019. More interesting news about VanEck Vectors Biotech ETF (NASDAQ:BBH) were released by: and their article: “Groupe Renault Gives A New Dimension To Its On-Boarded Editorial Content Platform And Enters Into A Strategic Agreement With Publicis Groupe – Nasdaq” published on May 16, 2019 as well as‘s news article titled: “The Best Biotech ETFs to Buy Ahead of ASCO – 24/7 Wall St.” with publication date: May 14, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.